The gene-editing market is projected to grow to $30.8 billion by 2032, highlighting investment potential. CRISPR Therapeutics, co-founder by Charpentier, gains momentum with FDA-approved therapies.

A quick-start project that demonstrates how to enable and use editing features in the Syncfusion Angular Data Grid component. This project includes simple code examples for enabling editing using the ...

Abstract: Highly sensitive dual-comb spectroscopy was demonstrated using background-suppressed spectral peaking. A high SNR of 38 dB and a large dynamic range of 50 dB were achieved for comb mode ...

CRISPR-Cas13 are robust RNA knockdown tools with both on-target and collateral cleavage activities. Here, the authors combine in vitro and in vivo methods to elucidate the exact cleavage sites of ...

A modern, full-stack construction estimation platform built for contractors, estimators, and project managers. Create projects, build detailed estimates with trade-level breakdowns, compare supplier ...